Ontology highlight
ABSTRACT: Importance
Immune-related adverse events (irAEs) due to immune checkpoint blockade (ICB) have been shown to be positively associated with survival. Among patients with metastatic melanoma, evidence supporting this association has been conflicting, while ipilimumab-nivolumab combination ICB has been examined only in small clinical cohorts.Objective
To examine the association between irAEs and survival among patients with metastatic melanoma, in particular for those receiving combination ICB.Design, setting, and participants
A retrospective cohort of 492 consecutive patients with metastatic melanoma treated with ICB at 2 tertiary and 4 regional cancer centers in Alberta, Canada, from August 1, 2013, to May 31, 2020, was observed. Patients were aged 18 years or older w
SUBMITTER: Watson AS
PROVIDER: S-EPMC9856439 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature